The manufacturer of Rotarix, GlaxoSmithKline, has released a statement indicating that they notified regulatory authorities about the presence of the virus, PCV-1, in its oral rotavirus vaccine. GlaxoSmithKline further stated that not only is PCV-1 not known to multiply in humans, it is found in everyday meat products and is frequently consumed without resulting in disease or illness¹.
An independent U.S. academic research team using a novel approach initially detected the contamination, which was subsequently verified during follow-up tests conducted by GlaxoSmithCline. The academic researchers as well as the FDA have tested another licensed vaccine for rotavirus, RotaTeq, for components of the PCV-1 virus with the results coming back negative. RotaTeq is manufactured by Merck.
Both Rotarix and RotaTeq are given to infants by mouth to prevent rotavirus, the leading cause of severe gastroenteritis among children below the age of five. Rotavirus kills one child per minute worldwide - more than half a million children each year ². The FDA licensed RotaTeq in 2006 and Rotarix in 2008. The majority of children in the United States are vaccinated with RotaTeq.
The FDA has stated that the risk from rotavirus is so great in many countries that the benefits of the vaccine far outweigh any potential risks and have recommended the continued use of the vaccine. GlaxoSmithKline is currently reviewing their procedures and are looking for the best way to replace the cell bank and virus seeds used as the base production material for Rotarix.
According to GlaxoSmithKline's website, worldwide Rotarix sales in 2009 were £282million with U.S. representing £76million.
The FDA has stated that it will continue to gather information about the PCV-1 components in Rotarix, including whether it is an intact virus as opposed to DNA fragments. The FDA intends to convene an expert advisory committee in four to six weeks to make additional recommendations regarding the use of rotavirus vaccines. The agency has said that it will continue to update providers and patients as well as the general public as more information becomes available.
Sources:
1- http://www.gsk.com/media/pressreleases/2010/2010_pressrelease_10029.htm
2- http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm205625.htm
Published by Kathrine Lloyd
Born and raised on the east coast of the United States and transplanted to Seattle in the Pacific Northwest, Kathrine caught nature fever and can be found out and about in Seattle s wild spaces photographing... View profile
- RotaShield Rotavirus Vaccine IngredientsRotaShield Rotavirus Vaccine Ingredients are not all innocuous, in fact some can be potentially harmful. One should always ask for the package insert and should have an understanding of all the ingredients in a vaccin...
Rotavirus Vaccine Could Save Millions of ChildrenA rotavirus vaccine could help to prevent potentially millions of cases of childhood diarrhea each year, and possibly save one to two million lives of children in the developing...- FDA Peanut Butter Warning is Not a Peanut Butter RecallThe first company to issue a peanut butter recall was King Nut on January 10. Other companies followed with peanut butter recalls. The FDA didn't make a statement until January 16.
- Preventing Rotavirus Infection in Your InfantWith persistence, parents can get their infant the Rotavirus vaccine needed to prevent one of the most common causes of severe diarrhea and vomiting in infancy.
FDA Issues Public Health Notice on RotaTeq VaccineThe Food and Drug Administration (FDA) today issues a public health warning on the RotaTeq vaccine after 28 cases of intussusception were reported after administration of the va...
- Rotavirus: Not for the Weak of Stomach
- The FDA's Warning About the Rotavirus Vaccine, RotaTeq
- New Rotavirus Vaccine Danger
- What You Need to Know About the Rotavirus Vaccine
- What is Rotavirus and How Do I Protect My Kids from It?
- Rotavirus: Symptoms, Treatment and Prevention
- Everything You Need To Know About Early Childhood Vaccinations
- The FDA has recommended that clinicians in the United States suspend the use of the vaccine Rotarix.
- Independent U.S. academic research team using a novel approach initially detected the contamination.
- The FDA does not believe there is a safety concern.



